SREBF1 and esophageal squamous cell carcinoma: We have for the first time elucidated the molecular mechanism (Figure8) by which ARL5B drives lipid metabolic reprogramming and malignant progression in ESCC through regulating the ROCK1‐mediated SREBP1 activation pathway.